Chikungunya's Long-Term Effects: 5 Joint and Fatigue Symptoms Indians Are Told to Ignore

The name chikungunya comes from a Makonde word meaning "to become contorted", a description of what prolonged joint pain actually looks like in a person's body. A 2017 study published in the Indian Journal of Medical Research found that nearly 49% of chikungunya patients in India still reported joint pain 20 months after their initial infection. This isn't residual soreness. It meets the clinical criteria for inflammatory arthritis.
The joints most affected are the small ones: fingers, wrists, ankles. Patients describe a stiffness that is worst in the morning, eases slightly by afternoon, and returns by evening. Most are handed a painkiller prescription and told the body will sort itself out. Many wait years for that to happen.
Post-chikungunya fatigue is different from being tired. Sleep doesn't fix it. A full night's rest produces the same outcome as four hours. The mechanism is believed to involve persistent low-grade inflammation affecting mitochondrial function, the cellular machinery that generates energy.
A 2019 review in the journal PLOS Neglected Tropical Diseases documented post-infectious fatigue as one of the most commonly reported long-term symptoms across chikungunya survivors in South and Southeast Asia. In India, where overwork is normalised and fatigue is rarely taken seriously as a standalone complaint, patients with this symptom are frequently told they are anxious or deconditioned. Neither diagnosis addresses what is actually happening.

Memory fog, difficulty concentrating, and peripheral tingling, numbness or pins-and-needles in the hands and feet, have been documented in chikungunya survivors well beyond the acute phase. These symptoms fall under the umbrella of post-viral neurological involvement, and chikungunya's affinity for nerve tissue has been confirmed in case studies from AIIMS Delhi and other major Indian research hospitals.
The problem is that these symptoms, particularly in patients over 40, are attributed to age, stress, or vitamin deficiency without any investigation into viral history. A patient who had chikungunya two years ago and now has intermittent hand numbness is unlikely to have the two events connected in a routine consultation.

Chikungunya's acute rash is well-known. Less discussed is what follows: recurring skin sensitivity, hyperpigmentation in patches, and in some cases, uveitis, inflammation of the middle layer of the eye. Uveitis linked to chikungunya has been reported in clusters across southern India, particularly following the 2006 outbreak that affected over 1.3 million people across Karnataka, Andhra Pradesh, and Maharashtra.
Patients with post-chikungunya uveitis often present to ophthalmologists months after the original infection, with no connecting history taken. The eye inflammation is treated as a standalone condition. The underlying trigger, a virus the immune system never fully resolved, goes unaddressed.

Chronic pain produces psychological distress. This is not a personality response; it is a physiological one. Sustained inflammation alters neurotransmitter pathways, and chikungunya's long-term inflammatory burden has been associated with elevated rates of depression and anxiety in survivors. A study from the Christian Medical College, Vellore, noted that quality-of-life scores among long-term chikungunya patients were significantly lower than matched controls, with mental health domains showing the steepest decline.
Indian patients with post-chikungunya depression face a compounded problem. The physical origin of their mental health symptoms is rarely identified, so they receive psychiatric treatment without the underlying inflammation being managed. The depression becomes the diagnosis, not the consequence.
What connects these five effects is that none of them require a new disease to explain them. They are all downstream of one infection that the immune system didn't fully clear. The body keeps responding to a threat that is technically gone, and the medical system keeps treating each response as a separate, unrelated complaint. The patient carries the whole picture. The clinical record holds only the parts.